Intravenous immunoglobulin for juvenile idiopathic arthritis

Julio C. Orellana; R. E. Pogonza; M. A. Lopez-Olivo; A. K. Roundtree; Z. Ortiz

doi:10.1002/14651858.CD006191

Intravenous immunoglobulin for juvenile idiopathic arthritis

Julio C. Orellana, R. E. Pogonza, M. A. Lopez-Olivo, A. K. Roundtree, Z. Ortiz

General Internal Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: The aim of this review is to determine the clinical effectiveness and safety of intravenous immunoglobulin for JIA. This review will address two core questions: 1. What is the clinical efficacy of intravenous immunoglobulin for the treatment of JIA in terms of controlling the disease and reducing joint counts? 2. What are the risks (frequency and severity of adverse events) associated with immunoglobulin treatment in these patients?

Original language	English (US)
Article number	CD006191
Journal	Cochrane Database of Systematic Reviews
Issue number	4
DOIs	https://doi.org/10.1002/14651858.CD006191
State	Published - 2006

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD006191

Cite this

@article{e7169d4a2af2403f9f10a70326b7c6c8,

title = "Intravenous immunoglobulin for juvenile idiopathic arthritis",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: The aim of this review is to determine the clinical effectiveness and safety of intravenous immunoglobulin for JIA. This review will address two core questions: 1. What is the clinical efficacy of intravenous immunoglobulin for the treatment of JIA in terms of controlling the disease and reducing joint counts? 2. What are the risks (frequency and severity of adverse events) associated with immunoglobulin treatment in these patients?",

author = "Orellana, {Julio C.} and Pogonza, {R. E.} and Lopez-Olivo, {M. A.} and Roundtree, {A. K.} and Z. Ortiz",

year = "2006",

doi = "10.1002/14651858.CD006191",

language = "English (US)",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Intravenous immunoglobulin for juvenile idiopathic arthritis

AU - Orellana, Julio C.

AU - Pogonza, R. E.

AU - Lopez-Olivo, M. A.

AU - Roundtree, A. K.

AU - Ortiz, Z.

PY - 2006

Y1 - 2006

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: The aim of this review is to determine the clinical effectiveness and safety of intravenous immunoglobulin for JIA. This review will address two core questions: 1. What is the clinical efficacy of intravenous immunoglobulin for the treatment of JIA in terms of controlling the disease and reducing joint counts? 2. What are the risks (frequency and severity of adverse events) associated with immunoglobulin treatment in these patients?

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: The aim of this review is to determine the clinical effectiveness and safety of intravenous immunoglobulin for JIA. This review will address two core questions: 1. What is the clinical efficacy of intravenous immunoglobulin for the treatment of JIA in terms of controlling the disease and reducing joint counts? 2. What are the risks (frequency and severity of adverse events) associated with immunoglobulin treatment in these patients?

UR - http://www.scopus.com/inward/record.url?scp=42749100737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42749100737&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD006191

DO - 10.1002/14651858.CD006191

M3 - Review article

AN - SCOPUS:42749100737

SN - 1469-493X

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 4

M1 - CD006191

ER -

Intravenous immunoglobulin for juvenile idiopathic arthritis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this